Literature DB >> 33027056

Pain management programmes via video conferencing: a rapid review.

Jackie Walumbe1,2, Joletta Belton3, Diarmuid Denneny1.   

Abstract

OBJECTIVES: During the current COVID-19 pandemic, healthcare has been transformed by the rapid switch from in person care to use of remote consulting, including video conferencing technology. Whilst much has been published on one-to-one video consultations, little literature exists on use of this technology to facilitate group interventions. Group pain management programmes are a core treatment provided by many pain services. This rapid review aimed to identify the extent of use of video conferencing technology for delivery of group pain management programmes and provide an overview of its use.
METHODS: A rapid review of the literature published up to April 2020 (PubMed, PsycINFO and PEDro) was performed. The search string consisted of three domains: pain/CP (MeSH term) AND Peer group[MeSH] AND Videoconferencing[MeSH]/Telemedicine[MeSH]/Remote Consultation[MeSH]. The studies were of poor methodological quality and study design, and interventions and chronic pain conditions were varied.
RESULTS: Literature searching yielded three eligible papers for this review. All studies had low methodological quality and risk of bias. Heterogeneity and variability in outcome reporting did not allow any pooling of data. The results demonstrated that videoconferencing for delivery of group programmes is possible, yet there is little extant literature on how to develop, deliver and measure outcomes of such programmes.
CONCLUSIONS: This review demonstrates that there is little evidence to support or guide the use of synchronous videoconferencing to deliver pain management programmes. We present issues to consider, informed by this review and our experience, when implementing video conferencing. Study quality of existing work is variable, and extensive future research is necessary.
© 2020 Jackie Walumbe et al., published by De Gruyter, Berlin/Boston.

Entities:  

Keywords:  chronic pain; pain management programme; tele health; video conferencing

Mesh:

Year:  2020        PMID: 33027056     DOI: 10.1515/sjpain-2020-0112

Source DB:  PubMed          Journal:  Scand J Pain        ISSN: 1877-8860


  5 in total

1.  A feasibility randomised controlled trial of a Fibromyalgia Self-management Programme for adults in a community setting with a nested qualitative study (FALCON).

Authors:  Jennifer Pearson; Jessica Coggins; Sandi Derham; Julie Russell; Nicola E Walsh; Erik Lenguerrand; Shea Palmer; Fiona Cramp
Journal:  BMC Musculoskelet Disord       Date:  2022-07-11       Impact factor: 2.562

2.  Multidimensional Statistical Technique for Interpreting the Spontaneous Breakthrough Cancer Pain Phenomenon. A Secondary Analysis from the IOPS-MS Study.

Authors:  Marco Cascella; Anna Crispo; Gennaro Esposito; Cira Antonietta Forte; Sergio Coluccia; Giuseppe Porciello; Alfonso Amore; Sabrina Bimonte; Sebastiano Mercadante; Augusto Caraceni; Massimo Mammucari; Paolo Marchetti; Rocco Domenico Mediati; Silvia Natoli; Giuseppe Tonini; Arturo Cuomo
Journal:  Cancers (Basel)       Date:  2021-08-10       Impact factor: 6.575

3.  What is the content of virtually delivered pain management programmes for people with persistent musculoskeletal pain? A systematic review.

Authors:  Gregory Booth; Deborah Williams; Hasina Patel; Anthony W Gilbert
Journal:  Br J Pain       Date:  2021-06-13

4.  Rapid design and implementation of a virtual pain management programme due to COVID-19: a quality improvement initiative.

Authors:  Deborah Williams; Gregory Booth; Helen Cohen; Anthony Gilbert; Andrew Lucas; Chloe Mitchell; Gayatri Mittal; Hasina Patel; Tamsin Peters; Mia Phillips; Will Rudge; Roxaneh Zarnegar
Journal:  Br J Pain       Date:  2021-09-03

5.  How to Best Develop and Deliver Generic Long-Term Condition Rehabilitation Programmes in Rural Settings: An Integrative Review.

Authors:  Amanda Wilkinson; Chris Higgs; Tim Stokes; Jack Dummer; Leigh Hale
Journal:  Front Rehabil Sci       Date:  2022-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.